Over half of acute Trusts now using electronic referrals

Over half of acute Trusts in England have replaced paper GP referrals with the NHS e-Referral Service (e-RS), NHS Digital has announced.

Paper referrals are being phased out across England this year and from 1 October providers will no longer be paid for activity which results from referrals that were not made through NHS e-RS.

So far, 79 Trust have transitioned over the e-RS with another 10 expected to switch off paper referrals by the end of June.

Trust were the first trusts to start processing all of their hospital referral appointments electronically via e-RS.

A new GP contract came into effect earlier this year, which includes a £10 million investment to help GP practices implement e-RS in primary care.

e-RS is intended the improve the efficiency of the referral management process by reducing the time taken to create and manage referrals. By improving communication between primary and secondary care,  the system aims to reduce the number of inappropriate referrals, ensuring patients are seen by the right person.

NHS Digital’s director of Implementation and the Digital Environment Eve Roodhouse said: “It is really encouraging that we have hit this major milestone and it’s an incredible achievement which is the result of a lot of hard work from all involved.

“e-RS puts the patient at the heart of the referral because it allows patients to book an appointment at a location, date and time that is convenient to them.

“Not only that, but the booking is immediate, speeding up the time it takes to be treated and reducing the number of appointments where the patient fails to attend by up to half.”

Reece Armstrong is a reporter for Digital Health Age. Coming from the North East of England, Reece has an MA in Media & Journalism and a BA in Popular & Contemporary Music from Newcastle University. Reach him on Twitter or email via: reece.armstrong@rapidnews.com

'Over half of acute Trusts now using electronic referrals' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2019 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.

Privacy policy

Terms and conditions